文献速递角膜与眼表疾病

抑制SGK1通过激活FoxO3a介导的自噬减轻干眼症凋亡与氧化应激

Inhibition of SGK1 Alleviates Apoptosis and Oxidative Stress in Dry Eye Disease by Activating FoxO3a-Mediated Autophagy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在高渗处理的人角膜上皮细胞和苯扎氯铵诱导的C57BL/6小鼠干眼模型中,探讨血清和糖皮质激素诱导激酶1(SGK1)的作用。结果显示SGK1表达上调,抑制SGK1可减轻眼表损伤、恢复泪液分泌、减少凋亡和氧化应激,机制依赖FoxO3a核转位激活自噬。

要点

  • 干眼症中SGK1表达上调,抑制SGK1可减轻眼表损伤并恢复泪液分泌。
  • SGK1抑制通过促进FoxO3a核转位激活自噬,减少凋亡和氧化应激。
  • FoxO3a敲低或自噬诱导剂雷帕霉素实验支持SGK1/FoxO3a/自噬轴的关键作用。

核心结论

  • 抑制SGK1通过激活FoxO3a介导的自噬减轻干眼症中的凋亡和氧化应激,SGK1可能成为潜在治疗靶点。

研究设计与样本

  • 体外采用高渗处理的人角膜上皮细胞(HCECs),体内采用苯扎氯铵诱导的C57BL/6小鼠干眼模型。
  • 使用GSK650394药理学抑制SGK1,并使用小干扰RNA对FoxO3a进行基因敲低。

主要发现

  • SGK1在高渗处理的HCECs和干眼小鼠角膜上皮中表达显著上调。
  • 抑制SGK1在体内外减轻眼表损伤、恢复泪液分泌、减少凋亡和氧化应激。
  • 抑制SGK1通过促进FoxO3a核转位和激活增强自噬流,FoxO3a敲低则消除SGK1抑制的保护作用。
  • 雷帕霉素诱导自噬可复制对干眼相关损伤的保护效应。

临床怎么用

  • SGK1/FoxO3a/自噬轴可能参与干眼症发病机制,SGK1抑制或为干眼治疗提供新方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to investigate the role of serum- and glucocorticoid-inducible kinase 1 (SGK1) in dry eye disease (DED) pathogenesis and its underlying molecular mechanisms. METHODS: We established in vitro hyperosmotic models using human corneal epithelial cells (HCECs) and in vivo DED models induced by benzalkonium chloride in C57BL/6 mice. SGK1 was inhibited pharmacologically with GSK650394, and genetic knockdown of Forkhead box O3a (FoxO3a) was performed using small interfering RNA. Comprehensive assessments included western blot for apoptosis and autophagy markers, flow cytometry for apoptosis and reactive oxygen species (ROS) detection, mRFP-GFP-LC3 lentiviral transfection for autophagic flux monitoring, transmission electron microscopy for autophagic ultrastructure, co-immunoprecipitation for protein interactions, immunofluorescence staining for cellular localization, and histological examinations of ocular tissues. RESULTS: SGK1 expression was significantly upregulated in both hyperosmotic-treated HCECs and the corneal epithelium of DED mice. SGK1 inhibition alleviated ocular surface damage, restored tear secretion, and reduced apoptosis and oxidative stress in vivo and in vitro. Mechanistically, SGK1 inhibition enhances autophagic flux by promoting FoxO3a nuclear translocation and activation, whereas FoxO3a knockdown abolishes the protective effects of SGK1 inhibition. Autophagy induction with rapamycin replicated the protective effects against DED-related damage. CONCLUSIONS: Inhibition of SGK1 alleviates apoptosis and oxidative stress in DED by activating FoxO3a-mediated autophagy. Our findings suggest that the SGK1/FoxO3a/autophagy axis may play a critical role in the pathogenesis of DED, and SGK1 may represent a potential therapeutic target for this condition.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tang Y, Chen Z, Jiang J, et al. Inhibition of SGK1 Alleviates Apoptosis and Oxidative Stress in Dry Eye Disease by Activating FoxO3a-Mediated Autophagy. Invest Ophthalmol Vis Sci. 2026. PMID: 42138516. doi:10.1167/iovs.67.5.37

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。